The development of de novo hepatocellular carcinoma in patients on a liver transplant list: Frequency, size, and assessment of current screening methods

Liver Transplantation

Volumn 10, Issue 5, 2004, Pages 631-637

  van Thiel, David H ^a,b   Yong, Sherri ^a   Li, S David ^a   Kennedy, Marc ^a   Brems, John ^a  

^a LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^b ST LUKE S MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ALPHA FETOPROTEIN; CONTRAST MEDIUM;

ADULT; ARTICLE; CANCER DIAGNOSIS; CANCER RISK; CANCER SCREENING; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DATA ANALYSIS; DIAGNOSTIC VALUE; ECHOGRAPHY; EXPLANT; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HOSPITAL ADMISSION; HUMAN; INCIDENCE; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER FAILURE; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; SCORING SYSTEM; TREATMENT INDICATION;

ALPHA-FETOPROTEINS; CARCINOMA, HEPATOCELLULAR; DISEASE PROGRESSION; FEMALE; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MASS SCREENING; MIDDLE AGED; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED; WAITING LISTS;

EID: 2442599423     PISSN: 15276465     EISSN: None     Source Type: Journal    
DOI: 10.1002/lt.20120     Document Type: Article

References (44)

1. Okuda K. Hepatocellular carcinoma: recent progress. Hepatology 1992;15:948-63.
2. Okuda K. Hepatocellular carcinoma. Hepatology 2000;32: 225-237.
3. Chiesa R, Donato F, Tagger A, Favret M, Ribero ML, Nardi G, et al. Etiology of hepatocellular carcinoma in Italian patients without cirrhosis. Cancer Epidemiology Biomarkers & Prevention 2000; 9:213-216.
4. Idilman R, De Maria N, Colantoni A, Van Thiel DH. Pathogenesis of hepatitis B and C-induced hepatocellular carcinoma. J Viral Hepatitis. 1998;5:285-299.
5. El-Serag HB. Hepatocellular carcinoma and hepatitis C in the United States. Hepatology 2002;36:(Suppl 1):S74-83.
6. El-Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 1999;340:745-750.
7. Chiaramonte M, Stroffolini T, Vian A, Stazi MA, Floreani A, Lorenzoni U, et al. Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis. Cancer 1999;85: 2132-2137.
8. Fattovich G. Progression of hepatitis B and C to hepatocellular carcinoma in western countries. Gastroenterology 1998;45: 1206-1213.
9. Bosch FX, Ribes J, Borras J. Epidemiology of primary liver cancer. Semin Liver Dis 1999;19:271-285.
10. Ikeda K, Saitoh S, Koida I, Arase Y, Tsubota A, Chayama K, et al. A multivariate analysis of risk factors for hepatocellular carcinogenesis: prospective observation of 795 patients with viral and alcoholic cirrhosis. Hepatology 1993;18:47-53.
11. Tiribelli C, Melato M, Crocè L, Ciarelli L, Okuda K, Ohnishi K. Prevalence of hepatocellular carcinoma and relation to cirrhosis: comparison of two different cities of the world - Trieste, Italy, and Chiba, Japan. Hepatology 1989;10:998-1002.
12. Beasley RP, Hwang LY, Lin CC, Chien CS. Hepatocellular carcinoma and hepatitis B virus: a prospective study of 22,707 men in Tiawan. Lancet 1981;2:1129-1133.
13. McMahon BJ. Alberts SR, Wainwright RB, Bulkow L, Lanier AP. Hepatitis B related sequelae. Prospective study in 1400 hepatitis B surface antigen-positive Alaska native carriers. Arch Intern Med 1990;150:1051-1054.
14. Silini E, Bottelli R, Asti M, Bruno S, Candusso ME, Brambilla S, et al. Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: a case-control Study. Gastroenterology 1996;111:199-205.
15. Tradati F, Colombo M, Mannucci PM, Rumi MG, De Fazio C, Gamba G, et al A prospective multicenter study of hepatocellular carcinoma in Italian hemophiliacs with chronic hepatitis C. Blood 1998;91:1173-1177.
16. Montalto G, Cervello M, Giannitrapani L, Dantona F, Terranova A, Castagnetta LAM. Epidemiology, risk factors, and natural history of hepatocellular carcinoma. Ann NY Acad Sci 2002;963:13-20.
17. Groopman JD, School P, Wang JS. Epidemiology of human aflatoxin exposures and their relationship to liver cancer. Prog Clin Biol Res 1996;395:211-222.
18. Theise ND. Cirrhosis and hepatocellular neoplasia: more like cousins than like parent and child. Gastroenterology 1996;111:526-528.
19. Kamath PS, Wiesner RH, Malinchoc M, Kremer W, Therneal TM, Kosberg CL, et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001;33:464-470.
20. Department of Health and Human Services Health Resources and Services Administration 2002 Annual Report. The US Organ Procurement and Transplantation Network and the Scientific Registry of Transplant Recipients. Transplant Data 1992-2001 pg 475-537.
21. Vargas V, Rimola A, Casanovas T, Castells L, Navasa M, Baliellas C, et al. Applicability of liver transplantation in Catalonia at the end of the millennium. A prospective study of adult patient selection for liver transplantation. Transpl Int 2003;16:270-275.
22. Fagiuali S, Mirante VG, Pompili M, Gianni S, Leandro G, Rapaccini GL, et al. Liver transplantation: the Italian experience. Dig Liver Dis 2002;34:619-620.
23. Southern PB, Davies MH. Indication and assessment for liver transplantation. Clin Med 2002;2:313-316.
24. Webberley M, Neuberger J. Changing indications in liver transplantation. Baillieres Clin Gastroenterol 1994;8:495-515.
25. Sibal A, Rajasekar MR, Soin AS. Liver transplantation in the developing world. Ital J Gastroenterol 1994;26:318-325.
26. Lee KH, Lo SK, Quak SH, Prabhakaran,Tan KC. Liver transplant in Singapore - coming of age. Singapore Med J 1998;39:49-52.
27. Stoker J, Romimn MG, de Man RA, Brouwer JT, Weverling GJ, van Muiswinkel JM,et al. prospective comparative study of spiral computer tomography and magnetic resonance imaging for detection of hepatocellular carcinoma. GUT 2002;51:105-107.
28. Ebara M, Ohito M, Shinagawa T. Natural history of minute hepatocellular carcinoma smaller than three centimeters complicating cirrhosis. Gastroenterology 1986;90:289-298.
29. Chalasani N, Said S, Ness R, Hoen H, Lumeng L. Screening for hepatocellular carcinoma in patients with cirrhosis in the United States: results of a national survey. Am J Gastroenterol 1999;94: 2224-2229.
30. Livraghi T, Bolondi L, Buscarini L, Cottone M, Mazziotti A, Morabito A, Torzilli G. No treatment, resection and ethanol injection in hepatocellular carcinoma: a retrospective analysis of survival in 391 patients with cirrhosis. J Hepatol 1995;22:522-526.
31. Kubota K, Ina H, Okada Y, Irie T. Growth rate of primary single hepatocellular carcinoma: determining optimal screening interval with contrast enhanced computed tomography. Dig Dis Sci 2003;48:581-586.
32. Federle MP. Use of radiologic techniques to screen for hepatocellular carcinoma. J Clin Gastroenterol 2002;35(Suppl 2);S92-S100.
33. Gebo KA, Chander G, Jenckes MW, Ghanem KG, Herlong F, Torbenson MS, et al. Screening tests for hepatocellular carcinoma in patients with chronic hepatitis C: a systemic review. Hepatology 2002;36:S84-S92.
34. Caturelli E, Bartolucci F, Biasini E, Vigliotti ML, Andriulli A, Siena DA, et al. Diagnosis of liver nodules observed in chronic liver disease patients during ultrasound screening for early detection of hepatocellular carcinoma. Am J Gastroenterol 2002;97:397-405.
35. Sherman M. Surveillance for hepatocellular carcinoma. Seminars in Oncology 2001;28:450-459.
36. Khakoo, SI, Grellier LFL, Soni PN, Bhattacharya S, Duscheiko GM. Etiology, screening, and treatment of hepatocellular carcinoma. Med Clin North America 1996;80:1121-1143.
37. Brancatelli G, Baron RL, Peterson MS, Marsh W. Helical CT screening for hepatocellufar carcinoma in patients with cirrhosis: frequency and causes of false-positive interpretation. AJR 180;1007-1014.
38. Kanematsu M, Hoshi H, Murakami T, Itoh K, Hori M, Kondo H, Nakamura H. Detection of hepatocellular carcinoma: comparison of low- and high-spatial-resolution dynamic MR images. AJR 1999;1207-1212.
39. Adam R, Del Gaudio M. Evolution of liver transplantation for hepatocellular carcinoma. J Hepatol 2003;39:888-895.
40. Bolondi L. Screening for hepatocellular carcinoma in cirrhosis. J Hepatol 2003;39:1076-1084.
41. Feng S, Buell JF, Chari RS, DiMaio JM, Hanto DW. Tumors and transplantation: the 2003 Third Annual ASTS Sate-of-the-Art Winter Symposium. Am J Transplant 2003;3:1481-1487.
42. Yao FY, Ferrell L, Bass NM, Bacchetti P, Ascher NL, Roberts JP. Liver transplantation for hepatocellular carcinoma: comparison of the proposed UCSF Criteria with the Milan criteria and the Pittsburgh modified TNM criteria. Liver Transpl 2002;8:765-774.
43. Yao FY, Bass NM, Nikolai B, Davern TJ, Kerlan R, Wu V, et al. Liver transplantation for hepatocellular carcinoma: analysis of survival according to the intention-to-treat principle and dropout from the waiting list. Liver Transpl 2002;8:873-883.
44. Mazzaferro V, Regalia E , Doci R, Andreola S, Pulvirenti A, Bozzetti F, et al. Liver transplantation for the treatment of small hepatocellular carcinoma in patients with cirrhosis. N Engl JMed 1996;334:693-699.